Respiratory

Latest News

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

February 13th 2025

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.

Sanofi | Image credit: Eagle - stock.adobe.com
Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com
Ambient Toxins Linked to Disabilities in Minority Schoolchildren

December 10th 2024

RSV vaccine | Image credit: Pawel - atock.adobe.com
Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

December 6th 2024

Doctor with an image of lungs | Image credit: lungs_PRASANNAPIX
Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

November 26th 2024

Continuing Medical Education
View All
April 25th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Studies Evaluate Nontuberculous Mycobacterial Lung Disease
May 30th 2018

Studies Evaluate Nontuberculous Mycobacterial Lung Disease

Alison Rodriguez
Studies presented at American Thoracic Society 2018 International Conference looked at video-assisted thoracoscopic surgery and drug resistance mutations in nontuberculous mycobacterial lung disease.
Interventions to Decrease Pediatric Hospital Readmission for Asthma Patients Are Not Effective
May 28th 2018

Interventions to Decrease Pediatric Hospital Readmission for Asthma Patients Are Not Effective

Alison Rodriguez
While knowledge and care for children with asthma has increased over time, overall morbidity has not decreased. A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission.
Two Studies Evaluate Non-Tuberculous Mycobacterium Causes and Identification
May 25th 2018

Two Studies Evaluate Non-Tuberculous Mycobacterium Causes and Identification

Alison Rodriguez
Non-tuberculous mycobacterium (NTM), a serious lung disease, can be identified in different ways in patients. Recently, 2 studies evaluated specific identification and causes of NTM in order to help predict treatment outcomes in the future.
Study: Mining Industry Noncompliance With Requirements Linked to Lung Disease Prevalence
May 20th 2018

Study: Mining Industry Noncompliance With Requirements Linked to Lung Disease Prevalence

Alison Rodriguez
Mines that are in compliance with the Mine Safety and Health Administration's requirements experience significantly lower lung disease cases over time compared with mines not in compliance. However, the lung disease burden among the coal mining industry has increased in the last decade.
Interprofessional Education Improves Students' Skills of Respiratory Therapy Profession
May 19th 2018

Interprofessional Education Improves Students' Skills of Respiratory Therapy Profession

Alison Rodriguez
A study found the use of interprofessional education improves students' knowledge and skill sets and promotes collaborative behaviors.
ICER Releases Draft Scoping Document on Biologics for Asthma
May 16th 2018

ICER Releases Draft Scoping Document on Biologics for Asthma

Allison Inserro
The Institute for Clinical and Economic Review (ICER) released a draft scoping document on new biologics for severe asthma. Public comment on the draft is open until June 5.
Study Finds Rise in Use of ADHD, Asthma Drugs in Children
May 15th 2018

Study Finds Rise in Use of ADHD, Asthma Drugs in Children

Allison Inserro
A new study published in JAMA showed that although estimates of prescription medication use for children and teens fell overall from 1999 to 2014, patterns differed by types of medications, with drugs for attention-deficit/hyperactivity disorder (ADHD), asthma, and contraception all increasing. Use of antibiotics, antihistamines, and upper respiratory combination medications decreased.
FDA Confirms Short-Term Shortages of EpiPen
May 9th 2018

FDA Confirms Short-Term Shortages of EpiPen

Allison Inserro
The FDA Wednesday confirmed that there are “intermittent” shortages of Mylan’s EpiPen, an autoinjector device containing epinephrine to counteract the effects of anaphylaxis, but said it expects the delay to be short, while the manufacturer said the issue has to do with supply of third-party components.
Site Logo
May 9th 2018

Study Touts CF Drug Ivacaftor as Prime Example of Precision Medicine

Allison Inserro
Ivacaftor, the first drug that targeted the underlying defect of cystic fibrosis (CF), which affects about 30,000 people in the United States, improved outcomes and reduced hospitalizations, according to an analysis in the May issue of Health Affairs examining precision medicine.
Air Pollution Linked to Lung Infections, Especially in Young Children
May 6th 2018

Air Pollution Linked to Lung Infections, Especially in Young Children

Allison Inserro
Exposure to a short-term increase in pollution-causing airborne particles called fine particulate matter 2.5 is linked to the development of acute lower respiratory infection in young children, as well as additional doctor visits, according to new research.
Study Finds Increased Risk of Psychiatric Disorders Linked to Asthma, Allergies
May 2nd 2018

Study Finds Increased Risk of Psychiatric Disorders Linked to Asthma, Allergies

Allison Inserro
Allergic diseases such as asthma were associated with a 1.66-fold increased hazard of psychiatric disorders in Taiwan, according to a large study published in Frontiers in Psychiatry.
FDA, FTC Warn 13 Firms for Selling Vaping Juice With Kid-Friendly Appeal
May 1st 2018

FDA, FTC Warn 13 Firms for Selling Vaping Juice With Kid-Friendly Appeal

Allison Inserro
The FDA and the FTC issued 13 warning letters Tuesday to manufacturers, distributors, and retailers for selling e-liquids used in e-cigarettes, or vaping devices, with labeling or advertising that bears stark resemblances to kid-friendly food products, such as juice boxes, candy, or cookies.
ICER to Review Five Biologic Drugs Used for Severe Asthma
April 30th 2018

ICER to Review Five Biologic Drugs Used for Severe Asthma

Allison Inserro
The Institute for Clinical and Economic Review (ICER) is going to review the class of biologic drugs used to treat moderate to severe eosinophilic asthma and release a report in November, the organization said.
Pulmonary Function Test Can Predict Risk of Pneumonitis in Patients With NSCLC on Chemoradiotherapy
April 26th 2018

Pulmonary Function Test Can Predict Risk of Pneumonitis in Patients With NSCLC on Chemoradiotherapy

Surabhi Dangi-Garimella, PhD
Researchers from Mexico recommend conducting a pulmonary function test in patients with non–small cell lung cancer (NSCLC) undergoing concurrent chemoradiotherapy to assess their susceptibility to developing radiation pneumonitis.
Study Recommends DNA Testing to Solve Legionnaires' Disease Outbreaks
April 12th 2018

Study Recommends DNA Testing to Solve Legionnaires' Disease Outbreaks

Allison Inserro
A DNA test method called polymerase chain reaction can shave days off the time it takes to detect a Legionnaires' disease outbreak to mere hours and should be implemented by health departments to prevent illness, a new study reported.
Site Logo
March 16th 2018

Assessing Medical Home Mechanisms: Certification, Asthma Education, and Outcomes

Nathan D. Shippee, PhD Michael Finch, PhD Douglas R. Wholey, PhD
Using statewide quality data for medical home–eligible clinics, we tested asthma education as a clinical mechanism whereby medical homes achieve better asthma outcomes.
Site Logo
February 17th 2018

Claims-Based Risk Model for First Severe COPD Exacerbation

Richard H. Stanford, PharmD, MS Arpita Nag, PhD, MBA, MS Douglas W. Mapel, MD Todd A. Lee, PhD Richard Rosiello, MD Michael Schatz, MD Francis Vekeman, MS Marjolaine Gauthier-Loiselle, PhD J.F. Philip Merrigan, PhD Mei Sheng Duh, ScD
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.
Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis
January 24th 2018

Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis

AJMC Staff
Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for people with arthritis and other physical limitations.
Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier
January 16th 2018

Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier

Allison Inserro
Cigarette smoking is the most common cause of chronic obstructive pulmonary disease (COPD), but not all smokers develop the condition, and many non-smokers do. Why that is has remained a mystery until now, as a research team, funded by the National Institutes of Health, has discovered genetic variations in the anatomy of the lungs could serve as early-warning indicators.
CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year
January 12th 2018

CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year

Allison Inserro
Asthma costs the U.S. economy more than $80 billion annually in medical expenses, days missed from work and school, and deaths, according to research published online in the Annals of the American Thoracic Society. However, actual numbers are likely to be higher, according to CDC researchers who conducted the study.
Study Shows Psychological Factors Affect Quality of Life in Patients With COPD
January 10th 2018

Study Shows Psychological Factors Affect Quality of Life in Patients With COPD

Kaitlynn Ely
Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.
Study Shows the Efficacy of Vaccination in Patients With COPD
January 3rd 2018

Study Shows the Efficacy of Vaccination in Patients With COPD

Kaitlynn Ely
Patients with chronic obstructive pulmonary disease should be given the pneumococcal conjugate vaccine and influenza vaccines to decrease the risk of exacerbations. However, despite the evidence of vaccine efficacy, improvements are needed in coverage and awareness.
Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD
December 25th 2017

Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD

Christina Mattina
Less than 10% of patients with chronic obstructive pulmonary disease (COPD) who may benefit from pulmonary rehabilitation received a referral from their physician, according to a new study. However, there was no association found between referral status and COPD exacerbations.
Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs
December 24th 2017

Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs

AJMC Staff
The FDA has removed a boxed warning on medicines delivering a combinations of inhaled corticosteroid (ICS) and long-acting beta agonists (LABA) drugs.
Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma
December 14th 2017

Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma

Laura Joszt, MA
Despite effective pharmacology, many patients with asthma have impaired quality of life, but a new breathing retraining intervention can be used as a nonpharmacological intervention to treat asthma.
FDA Announces Public Education Campaign to Encourage Smoking Cessation
December 14th 2017

FDA Announces Public Education Campaign to Encourage Smoking Cessation

Jaime Rosenberg
The FDA has announced its launch of the “Every Try Counts” campaign, which will encourage smokers to quit by advertising messages of support underscoring the health benefits of quitting. The campaign will also focus on celebrating each quit attempt as a step towards success.
Site Logo
December 8th 2017

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Trisha M. Parekh, DO Surya P. Bhatt, MD Andrew O. Westfall, MS James M. Wells, MD deNay Kirkpatrick, DNP, APN-BC Anand S. Iyer, MD Michael Mugavero, MD James H. Willig, MD Mark T. Dransfield, MD
Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.
Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries
December 5th 2017

Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries

Laura Joszt, MA
A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.
Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid
November 29th 2017

Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid

Laura Joszt, MA
High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.
Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers
November 21st 2017

Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers

Christina Mattina
Data from a study of smokers with chronic obstructive pulmonary disease (COPD) indicate that the concentration of eosinophils in the sputum, rather than the blood, is a better predictor of COPD exacerbations and lung function.
<1
...
16171819202122>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo